LORAZEPAM Side Effects

6762845-2 | Sedation
on Jun 08, 2010 Male patient from UNITED STATES , 53 years of age, weighting 160.0 lb, was treated with Lorazepam (View Usage). Patient experienced the following unwanted or unexpected effects: sedation. Lorazepam dosage: 1 Mg Once Po. Patient was hospitalized.

6762840-3 | Anxiety, Product Substitution Issue
Patient was taking Lorazepam (View Usage). Patient had the following side effects: anxiety (What is anxiety?), product substitution issue on Jun 08, 2010 from UNITED STATES Additional patient health information: Male patient , 61 years of age, weighting 409.0 lb, was diagnosed with anxiety (What is anxiety?) and. Lorazepam dosage: 1 Mg Qid Po.

6760715-7 | Anxiety, Dyspnoea, Product Substitution Issue, Tachycardia
Adverse event was reported on Jun 07, 2010 by a Female patient taking Lorazepam (View Usage) (Dosage: 1 Tablet 4 Times Daily Po) was diagnosed with anxiety disorder, panic disorder (What is panic disorder?) and. Location: UNITED STATES , 38 years of age, weighting 170.0 lb, After Lorazepam was administered, patient had the following side effects: anxiety (What is anxiety?), dyspnoea, product substitution issue, tachycardia. Patient was hospitalized.

6760519-5 | Asthenia, Cognitive Disorder, Delirium, Encephalopathy, Incoherent, Posture Abnormal
on Jun 07, 2010 Female patient from UNITED STATES , weighting 149.9 lb, was diagnosed with crying, depression (What is depression?), screaming and was treated with Lorazepam (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, cognitive disorder, delirium, encephalopathy, incoherent, posture abnormal. Lorazepam dosage: 2mg Stat Po. During the same period patient was treated with CLOZAPINE (View Clozapine Review and Clozapine Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), NALTREXONE HYDROCHLORIDE (View Naltrexone Hydrochloride Review and Naltrexone Hydrochloride Label ), ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ). Patient was hospitalized.


6760072-6 | Central Nervous System Lesion, Neuroleptic Malignant Syndrome
on May 25, 2010 Female patient from MALAYSIA , 32 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?), infection (What is infection?) and was treated with Lorazepam (View Usage). Patient had the following side effects: central nervous system lesion, neuroleptic malignant syndrome. Lorazepam dosage: 1 Mg, Bid. During the same period patient was treated with LITHIUM (300 Mg, Unk) (View Lithium Review and Lithium Label ), BENZHEXOL (4 Mg, Tid) (View Benzhexol Review and Benzhexol Label ), CLOMAZAPINE (10 Mg, Qd) (View Clomazapine Review and Clomazapine Label ), CEFTRIAXONE (1 G, Bid) (View Ceftriaxone Review and Ceftriaxone Label ), C PENICILLIN (Unk) (View C-penicillin Review and C-penicillin Label ). Patient was hospitalized.

6745981-6 | Anxiety, Condition Aggravated, Delusion Of Reference, Dysphagia, Dysphonia, Dyspnoea, Hallucination, Auditory, Myasthenia Gravis, Oxygen Saturation Decreased
Patient was taking Lorazepam (View Usage). After Lorazepam was administered, patient had the following side effects: anxiety (What is anxiety?), condition aggravated, delusion of reference, dysphagia, dysphonia, dyspnoea, hallucination, auditory, myasthenia gravis, oxygen saturation decreased on May 11, 2010 from TAIWAN, PROVINCE OF CHINA Additional patient health information: Female patient , 26 years of age, . Lorazepam dosage: 1.5mg/day. During the same period patient was treated with AMISULPRIDE (AMISULPRIDE) (200-400mg/day) (View Amisulpride (amisulpride) Review and Amisulpride (amisulpride) Label ), QUETIAPINE ({200mg/day) (View Quetiapine Review and Quetiapine Label ), ARIPIPRAZOLE ({10mg/day) (View Aripiprazole Review and Aripiprazole Label ), CLOZAPINE ({50mg/day) (View Clozapine Review and Clozapine Label ), BIPERIDEN HYDROCHLORIDE TAB (1.5mg/day) (View Biperiden Hydrochloride Tab Review and Biperiden Hydrochloride Tab Label ). Patient was hospitalized.

6745105-5 | Myasthenia Gravis, Respiratory Failure
Adverse event was reported on May 17, 2010 by a Female patient taking Lorazepam (View Usage) (Dosage: 1.5 Mg, Daily) was diagnosed with tardive dyskinesia, schizophrenia and. Location: TAIWAN, PROVINCE OF CHINA , 26 years of age, Patient experienced the following unwanted or unexpected effects: myasthenia gravis, respiratory failure. During the same period patient was treated with BIPIDEN (1.5 Mg Daily) (View Bipiden Review and Bipiden Label ), QUETIAPINE (200 Mg Daily) (View Quetiapine Review and Quetiapine Label ), ARIPIPRAZOLE (10 Mg Daily) (View Aripiprazole Review and Aripiprazole Label ), CLOZAPINE (50 Mg Daily) (View Clozapine Review and Clozapine Label ).

6744713-5 | Dizziness, Palpitations
on May 26, 2010 Female patient from UNITED STATES , weighting 150.0 lb, was diagnosed with panic disorder (What is panic disorder?) and was treated with Lorazepam (View Usage). Patient had the following side effects: dizziness (What is dizziness?), palpitations. Lorazepam dosage: 1 Daily Po.

6743159-3 | Central Nervous System Lesion, Neuroleptic Malignant Syndrome
on May 13, 2010 Female patient from MALAYSIA , 32 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?), infection (What is infection?) and was treated with Lorazepam (View Usage). After Lorazepam was administered, patient had the following side effects: central nervous system lesion, neuroleptic malignant syndrome. Lorazepam dosage: 1 Mg, Bid. During the same period patient was treated with LITHIUM CARBONATE (300 Mg, Unk) (View Lithium Carbonate Review and Lithium Carbonate Label ), TRIHEXYPHENIDYL HCL (4 Mg, Tid) (View Trihexyphenidyl Hcl Review and Trihexyphenidyl Hcl Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), C PENICILLIN (View C-penicillin Review and C-penicillin Label ), CLOMAZAPINE (10 Mg, Unk) (View Clomazapine Review and Clomazapine Label ). Patient was hospitalized.

6738778-4 | Anxiety, Condition Aggravated, Intentional Self-injury, Lethargy, Panic Attack, Suicidal Behaviour, Suicidal Ideation
Patient was taking Lorazepam (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), condition aggravated, intentional self-injury, lethargy, panic attack, suicidal behaviour, suicidal ideation on May 11, 2010 from UNITED STATES Additional patient health information: Female patient , 27 years of age, was diagnosed with anxiety (What is anxiety?), panic attack and. Lorazepam dosage: 7 - 8 Mg, Daily (prescribed To Take 1 Tablet Qid). Patient was hospitalized.

6738069-1 | Anxiety, Condition Aggravated, Dysphagia, Dysphonia, Myasthenia Gravis, Psychotic Disorder, Respiratory Failure, Salivary Hypersecretion, Tardive Dyskinesia
Adverse event was reported on May 05, 2010 by a Female patient taking Lorazepam (View Usage) (Dosage: 1.5 Mg/day) . Location: TAIWAN, PROVINCE OF CHINA , 26 years of age, Patient had the following side effects: anxiety (What is anxiety?), condition aggravated, dysphagia, dysphonia, myasthenia gravis, psychotic disorder (What is psychotic disorder?), respiratory failure, salivary hypersecretion, tardive dyskinesia. During the same period patient was treated with AMISULPRIDE (AMISULPRIDE) (240-400 Mg/day) (View Amisulpride (amisulpride) Review and Amisulpride (amisulpride) Label ), QUETIAPINE (Less Than Or Equal To 200mg/day) (View Quetiapine Review and Quetiapine Label ), ARIPIPRAZOLE (Less Than Or Equal To 10mg/day) (View Aripiprazole Review and Aripiprazole Label ), CLOZAPINE (Less Than Or Equal To 50mg/day) (View Clozapine Review and Clozapine Label ), BIPERIDEN HYDROCHLORIDE TAB (1.5mg/day) (View Biperiden Hydrochloride Tab Review and Biperiden Hydrochloride Tab Label ). Patient was hospitalized.

6737576-5 | Bradyphrenia, Depression, Overdose, Pyrexia, Somnolence
on May 03, 2010 Female patient from SPAIN , weighting 119.0 lb, was diagnosed with ovarian cancer, neoplasm malignant, pain (What is pain?), depression (What is depression?), vomiting and was treated with Lorazepam (View Usage). After Lorazepam was administered, patient had the following side effects: bradyphrenia, depression (What is depression?), overdose, pyrexia, somnolence. Lorazepam dosage: (df). During the same period patient was treated with IMC 3Q3 (RH ANTI PDGFRA MAB) ((1080 Mg, Frequency: 1 In 2 Wk Intravenous ( Not Otherwise Specified))) (View Imc-3q3 (rh Anti-pdgfra Mab) Review and Imc-3q3 (rh Anti-pdgfra Mab) Label ), DOXORUBICIN HCL ((61.76 Mg, Frequency: 1 In 4 Week Intravenous (not Otherwise Spcified)) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), PHENTANYL (PHENTANYL) (NOT SPECIFIED) ((df)) (View Phentanyl (phentanyl) (not Specified) Review and Phentanyl (phentanyl) (not Specified) Label ), FLUOXETINE ((df)) (View Fluoxetine Review and Fluoxetine Label ), MORPHINE ((df)) (View Morphine Review and Morphine Label ), TRAZODONE HCL ((df)) (View Trazodone Hcl Review and Trazodone Hcl Label ), ONDANSETRON ((df)) (View Ondansetron Review and Ondansetron Label ), HALOPERIDOL ((df)) (View Haloperidol Review and Haloperidol Label ). Patient was hospitalized.

6732891-3 | Agitation, Inadequate Analgesia
on May 06, 2010 Male patient from UNITED KINGDOM , 30 years of age, was diagnosed with agitation and was treated with Lorazepam (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, inadequate analgesia. Lorazepam dosage: 8 Mg On Post-injury Day 6. During the same period patient was treated with MORPHINE SULFATE INJ (View Morphine Sulfate Inj Review and Morphine Sulfate Inj Label ), HALOPERIDOL (WATSON LABORATORIES) (37 Mg On Post-injury Day 6) (View Haloperidol (watson Laboratories) Review and Haloperidol (watson Laboratories) Label ), BUPRENORPHINE (2 Mg/ 0.5 Mg, Started Day 4 Post-injury) (View Buprenorphine Review and Buprenorphine Label ), MIDAZOLAM HCL (17 Mg On Post-injury Day 6) (View Midazolam Hcl Review and Midazolam Hcl Label ). Patient was hospitalized.

6731163-0 | Delusion, Hallucination, Auditory, Muscular Weakness, Respiratory Failure
Patient was taking Lorazepam (View Usage). Patient had the following side effects: delusion, hallucination, auditory, muscular weakness, respiratory failure on May 17, 2010 from Additional patient health information: Female patient , 26 years of age, . Lorazepam dosage: 1.5 Mg. During the same period patient was treated with QUETIAPINE (View Quetiapine Review and Quetiapine Label ), ARIPIPRAZOLE (View Aripiprazole Review and Aripiprazole Label ), CLOZAPINE (View Clozapine Review and Clozapine Label ), BIPIDEN (1.5 Mg) (View Bipiden Review and Bipiden Label ). Patient was hospitalized.

6728273-0 | Accidental Overdose, Lactic Acidosis
Adverse event was reported on May 04, 2010 by a Male patient taking Lorazepam (View Usage) (Dosage: 2mg/min) was diagnosed with accidental overdose, grand mal convulsion and. Location: UNITED STATES , 50 years of age, After Lorazepam was administered, patient had the following side effects: accidental overdose, lactic acidosis.

6725230-5 | Abnormal Behaviour, Coma, Tachycardia, Vomiting
on May 02, 2010 Female patient from ITALY , 30 years of age, was treated with Lorazepam (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, coma, tachycardia, vomiting. Lorazepam dosage: .

6722338-5 | Anxiety, Dysphagia, Dysphonia, Dyspnoea, Endotracheal Intubation, Myasthenia Gravis, Respiratory Failure, Tardive Dyskinesia
on May 05, 2010 Female patient from TAIWAN, PROVINCE OF CHINA , 26 years of age, was diagnosed with schizophrenia and was treated with Lorazepam (View Usage). Patient had the following side effects: anxiety (What is anxiety?), dysphagia, dysphonia, dyspnoea, endotracheal intubation, myasthenia gravis, respiratory failure, tardive dyskinesia. Lorazepam dosage: 1.5 Mg/day. During the same period patient was treated with AMISULPRIDE (NGX) (Dosages Ranging From 200 To 400 Mg/day) (View Amisulpride (ngx) Review and Amisulpride (ngx) Label ), QUETIAPINE (NGX) (Up To 200 Mg/day) (View Quetiapine (ngx) Review and Quetiapine (ngx) Label ), ARIPIPRAZOLE (Upt O 10 Mg/day) (View Aripiprazole Review and Aripiprazole Label ), CLOZAPINE (Up To 50 Mg/day) (View Clozapine Review and Clozapine Label ), BIPERIDEN HYDROCHLORIDE (NGX) (1.5 Mg/day) (View Biperiden Hydrochloride (ngx) Review and Biperiden Hydrochloride (ngx) Label ). Patient was hospitalized.

6719562-4 | Chemical Poisoning
Patient was taking Lorazepam (View Usage). After Lorazepam was administered, patient had the following side effects: chemical poisoning on May 10, 2010 from UNITED STATES Additional patient health information: Female patient , 59 years of age, weighting 214.5 lb, . Lorazepam dosage: Titrated Continuous Iv Drip. Patient was hospitalized.

6717736-X | Accidental Overdose, Alcohol Poisoning, Anoxic Encephalopathy, Cardiac Arrest, Choking, Grand Mal Convulsion, Hypotension
Adverse event was reported on May 03, 2010 by a Male patient taking Lorazepam (View Usage) (Dosage: ) was diagnosed with grand mal convulsion, hypotension, blood bicarbonate decreased, lactic acidosis and. Location: , 50 years of age, Patient experienced the following unwanted or unexpected effects: accidental overdose, alcohol poisoning, anoxic encephalopathy, cardiac arrest (What is cardiac arrest?), choking (What is choking?), grand mal convulsion, hypotension. During the same period patient was treated with COCAINE (View Cocaine Review and Cocaine Label ), ALCOHOL (View Alcohol Review and Alcohol Label ), NOREPINEPHRINE (View Norepinephrine Review and Norepinephrine Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), FOMEPIZOLE (View Fomepizole Review and Fomepizole Label ).

6716774-0 | Blister, Coma, Coma Blister, Disorientation, Hyperhidrosis, Necrosis, Overdose, Suicide Attempt, Sweat Gland Disorder
on Apr 26, 2010 Male patient from SPAIN , 41 years of age, was diagnosed with suicide attempt and was treated with Lorazepam (View Usage). Patient had the following side effects: blister, coma, coma blister, disorientation, hyperhidrosis, necrosis, overdose, suicide attempt, sweat gland disorder. Lorazepam dosage: .

6714437-9 | Blister, Coma
on Apr 26, 2010 Male patient from SPAIN , 41 years of age, was diagnosed with suicide attempt and was treated with Lorazepam (View Usage). After Lorazepam was administered, patient had the following side effects: blister, coma. Lorazepam dosage: Unk.

6712286-9 | Coma, Intentional Self-injury, Tachycardia, Vomiting
Patient was taking Lorazepam (View Usage). Patient experienced the following unwanted or unexpected effects: coma, intentional self-injury, tachycardia, vomiting on Apr 21, 2010 from ITALY Additional patient health information: Female patient , 30 years of age, . Lorazepam dosage: .

6704469-9 | Accidental Overdose, Haemodialysis, Lactic Acidosis
Adverse event was reported on Apr 22, 2010 by a Male patient taking Lorazepam (View Usage) (Dosage: 2 Mg/min During 10 Hours) was diagnosed with grand mal convulsion and. Location: UNITED STATES , 50 years of age, Patient had the following side effects: accidental overdose, haemodialysis, lactic acidosis. During the same period patient was treated with PROPYLENE GLYCOL (2 Mg/min During 10 Hours) (View Propylene Glycol Review and Propylene Glycol Label ). Patient was hospitalized.

6694897-2 | Malaise, Somnolence
on Apr 06, 2010 Male patient from UNITED KINGDOM , 50 years of age, was treated with Lorazepam (View Usage). After Lorazepam was administered, patient had the following side effects: malaise, somnolence. Lorazepam dosage: 4 Mg;qd. During the same period patient was treated with ABILIFY (View Abilify Review and Abilify Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ). Patient was hospitalized.

6693725-9 | Hypothermia, Intentional Overdose, Rhabdomyolysis, Somnolence, Suicide Attempt
on Apr 19, 2010 Female patient from GERMANY , 69 years of age, was treated with Lorazepam (View Usage). Patient experienced the following unwanted or unexpected effects: hypothermia (What is hypothermia?), intentional overdose, rhabdomyolysis, somnolence, suicide attempt. Lorazepam dosage: . During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), ROHYPNOL (View Rohypnol Review and Rohypnol Label ). Patient was hospitalized.

6692416-8 | Blister, Coma, Confusional State, Erythema, Hyperhidrosis, Intentional Overdose, Oedema, Suicide Attempt, Tachycardia
Patient was taking Lorazepam (View Usage). Patient had the following side effects: blister, coma, confusional state, erythema, hyperhidrosis, intentional overdose, oedema, suicide attempt, tachycardia on Apr 14, 2010 from SPAIN Additional patient health information: Female patient , 41 years of age, was diagnosed with asthma (What is asthma?) and. Lorazepam dosage: Two Empty Strips Of Lorazepam (besides The Patient's Body). During the same period patient was treated with BRONCHODILATORS (View Bronchodilators Review and Bronchodilators Label ). Patient was hospitalized.

6690868-0 | Blister, Coma, Hyperhidrosis, Overdose, Tachycardia
Adverse event was reported on Apr 07, 2010 by a Male patient taking Lorazepam (View Usage) (Dosage: ) . Location: SPAIN , 41 years of age, After Lorazepam was administered, patient had the following side effects: blister, coma, hyperhidrosis, overdose, tachycardia. Patient was hospitalized.

6687363-1 | Agitation, Patient Restraint
on Apr 16, 2010 Male patient from UNITED STATES , 60 years of age, weighting 168.4 lb, was diagnosed with agitation and was treated with Lorazepam (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, patient restraint. Lorazepam dosage: 3 Mg Other Iv. Patient was hospitalized.

6684775-7 | Blister, Coma
on Apr 06, 2010 Male patient from SPAIN , 41 years of age, was diagnosed with suicide attempt and was treated with Lorazepam (View Usage). Patient had the following side effects: blister, coma. Lorazepam dosage: Unk.

6683570-2 | Adverse Event
Patient was taking Lorazepam (View Usage). After Lorazepam was administered, patient had the following side effects: adverse event on Mar 31, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 50 years of age, . Lorazepam dosage: 4 Mg;qd. During the same period patient was treated with ABILIFY (View Abilify Review and Abilify Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ). Patient was hospitalized.

6681750-3 | Suicidal Ideation
Adverse event was reported on Apr 06, 2010 by a Male patient taking Lorazepam (View Usage) (Dosage: 1 Tablet, Tid Prn) was diagnosed with anxiety (What is anxiety?), depression (What is depression?), affective disorder and. Location: UNITED STATES , 17 years of age, Patient experienced the following unwanted or unexpected effects: suicidal ideation. During the same period patient was treated with PROZAC (View Prozac Review and Prozac Label ), ABILIFY (View Abilify Review and Abilify Label ), TOPAMAX (View Topamax Review and Topamax Label ). Patient was hospitalized.

6680005-0 | Accidental Overdose, Lactic Acidosis
on Apr 02, 2010 Male patient from UNITED STATES , 50 years of age, was diagnosed with grand mal convulsion and was treated with Lorazepam (View Usage). Patient had the following side effects: accidental overdose, lactic acidosis. Lorazepam dosage: .

6678941-4 | Blister, Coma, Depressed Level Of Consciousness, Suicide Attempt, Tachycardia
on Apr 08, 2010 Male patient from , 41 years of age, was treated with Lorazepam (View Usage). After Lorazepam was administered, patient had the following side effects: blister, coma, depressed level of consciousness, suicide attempt, tachycardia. Lorazepam dosage: . During the same period patient was treated with ANEXATE (View Anexate Review and Anexate Label ). Patient was hospitalized.

6674074-1 | Blister, Coma, Overdose
Patient was taking Lorazepam (View Usage). Patient experienced the following unwanted or unexpected effects: blister, coma, overdose on Mar 26, 2010 from SPAIN Additional patient health information: Male patient , 41 years of age, was diagnosed with suicide attempt and. Lorazepam dosage: .

6668653-5 | No Adverse Event
Adverse event was reported on Mar 19, 2010 by a Male patient taking Lorazepam (View Usage) (Dosage: 4 Mg;qd) . Location: UNITED KINGDOM , 50 years of age, Patient had the following side effects: no adverse event. During the same period patient was treated with ABILIFY (View Abilify Review and Abilify Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ). Patient was hospitalized.

6666763-X | Libido Increased
on Mar 22, 2010 Female patient from PORTUGAL , 62 years of age, was diagnosed with insomnia, hypertension and was treated with Lorazepam (View Usage). After Lorazepam was administered, patient had the following side effects: libido increased. Lorazepam dosage: 1 Mg, Unk. During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ), DIAZEPAM (5 Mg, Qd) (View Diazepam Review and Diazepam Label ).

6662868-8 | Movement Disorder, Nervousness, Somnolence
on Mar 18, 2010 Male patient from SPAIN , 40 years of age, was treated with Lorazepam (View Usage). Patient experienced the following unwanted or unexpected effects: movement disorder (What is movement disorder?), nervousness, somnolence. Lorazepam dosage: 2 Mg, Qd. During the same period patient was treated with VALERIAN/PASSIONFLOWER EXTRACT (300mg/380 Mg) (View Valerian/passionflower Extract Review and Valerian/passionflower Extract Label ).

6656860-7 | Dizziness, Hearing Impaired, Insomnia, Withdrawal Syndrome
Patient was taking Lorazepam (View Usage). Patient had the following side effects: dizziness (What is dizziness?), hearing impaired, insomnia, withdrawal syndrome on Mar 29, 2010 from UNITED STATES Additional patient health information: Female patient , 57 years of age, weighting 110.0 lb, was diagnosed with anxiety (What is anxiety?) and. Lorazepam dosage: 1/4 Mg. Twice Daily Po.

6653537-9 | Breast Cancer, Disturbance In Sexual Arousal, Initial Insomnia
Adverse event was reported on Mar 25, 2010 by a Female patient taking Lorazepam (View Usage) (Dosage: 1 Mg) was diagnosed with initial insomnia, hypertension, breast cancer (What is breast cancer?) and. Location: , 62 years of age, After Lorazepam was administered, patient had the following side effects: breast cancer (What is breast cancer?), disturbance in sexual arousal, initial insomnia. During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ), DIAZEPAM (5 Mg) (View Diazepam Review and Diazepam Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), DOCETAXEL (View Docetaxel Review and Docetaxel Label ).

6648620-8 | Crying, Hyperhidrosis, Respiratory Depression, Unresponsive To Stimuli
on Mar 03, 2010 Male patient from UNITED STATES , weighting 185.0 lb, was treated with Lorazepam (View Usage). Patient experienced the following unwanted or unexpected effects: crying, hyperhidrosis, respiratory depression, unresponsive to stimuli. Lorazepam dosage: Once Every Two Hours, Crushed And Dissolved Oral. During the same period patient was treated with OXYCONTIN (View Oxycontin Review and Oxycontin Label ), METHADONE HCL ((once Every 12 Hrs, Crush And Dissolved In Water Oral)) (View Methadone Hcl Review and Methadone Hcl Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ), MEGESTROL ACETATE (View Megestrol Acetate Review and Megestrol Acetate Label ), METOCLOPRAMIDE HYDROCHLORIDE (View Metoclopramide Hydrochloride Review and Metoclopramide Hydrochloride Label ).

6647584-0 | Lethargy
on Mar 23, 2010 Male patient from UNITED STATES , 47 years of age, weighting 188.8 lb, was treated with Lorazepam (View Usage). Patient had the following side effects: lethargy. Lorazepam dosage: 4 Mg Other Iv. Patient was hospitalized.

6645313-8 | Somnolence, Victim Of Sexual Abuse
Patient was taking Lorazepam (View Usage). After Lorazepam was administered, patient had the following side effects: somnolence, victim of sexual abuse on Mar 08, 2010 from FRANCE Additional patient health information: Female patient , 25 years of age, . Lorazepam dosage: Unk.

6644745-1 | Cardio-respiratory Arrest, Respiratory Depression, Sedation, Unresponsive To Stimuli
Adverse event was reported on Mar 18, 2010 by a Male patient taking Lorazepam (View Usage) (Dosage: 0.5 Mg Prn Im) was diagnosed with agitation and. Location: UNITED STATES , 60 years of age, weighting 172.0 lb, Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, respiratory depression, sedation, unresponsive to stimuli.

6639484-7 | Libido Increased
on Mar 04, 2010 Female patient from PORTUGAL , 62 years of age, was diagnosed with insomnia and was treated with Lorazepam (View Usage). Patient had the following side effects: libido increased. Lorazepam dosage: 1 Mg, Unk.

6635042-9 | Anxiety, Movement Disorder, Palpitations, Somnolence
on Mar 11, 2010 Male patient from , 40 years of age, was treated with Lorazepam (View Usage). After Lorazepam was administered, patient had the following side effects: anxiety (What is anxiety?), movement disorder (What is movement disorder?), palpitations, somnolence. Lorazepam dosage: 2 Mg. During the same period patient was treated with VALERIAN (View Valerian Review and Valerian Label ), PASSIONFLOWER (View Passionflower Review and Passionflower Label ).

6633771-4 | Movement Disorder, Somnolence
Patient was taking Lorazepam (View Usage). Patient experienced the following unwanted or unexpected effects: movement disorder (What is movement disorder?), somnolence on Mar 01, 2010 from SPAIN Additional patient health information: Male patient , 40 years of age, . Lorazepam dosage: 2 Mg, Qd.

6616990-2 | Blister, Coma, Confusional State, Erythema, Hyperhidrosis, Overdose, Suicide Attempt, Tachycardia
Adverse event was reported on Feb 15, 2010 by a Male patient taking Lorazepam (View Usage) (Dosage: Once, Oral) was diagnosed with suicide attempt and. Location: SPAIN , 41 years of age, Patient had the following side effects: blister, coma, confusional state, erythema, hyperhidrosis, overdose, suicide attempt, tachycardia.

6616391-7 | Intentional Overdose, Somnolence, Suicide Attempt
on Feb 21, 2010 Male patient from GERMANY , 63 years of age, was diagnosed with intentional overdose and was treated with Lorazepam (View Usage). After Lorazepam was administered, patient had the following side effects: intentional overdose, somnolence, suicide attempt. Lorazepam dosage: . Patient was hospitalized.

6610904-7 | Anxiety, Dizziness, Movement Disorder, Muscle Fatigue, Myalgia, Nervousness, Palpitations, Somnolence
on Feb 08, 2010 Male patient from SPAIN , 40 years of age, was treated with Lorazepam (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), dizziness (What is dizziness?), movement disorder (What is movement disorder?), muscle fatigue, myalgia, nervousness, palpitations, somnolence. Lorazepam dosage: 2 Mg/24 Hours, Oral. During the same period patient was treated with VALERIAN (300mg Qd X2, Then 900mg Qd, Po) (View Valerian Review and Valerian Label ), PASSIONFLOWER (Qd X1, Then 1140mg Qd, Oral) (View Passionflower Review and Passionflower Label ).

6608602-9 | Epistaxis, Face Injury, Fall, Lethargy, Somnolence
Patient was taking Lorazepam (View Usage). Patient had the following side effects: epistaxis, face injury, fall (What is fall?), lethargy, somnolence on Feb 26, 2010 from UNITED STATES Additional patient health information: Male patient , 68 years of age, weighting 180.0 lb, . Lorazepam dosage: 3.75mg Po. During the same period patient was treated with RISPERIDONE (View Risperidone Review and Risperidone Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), MIRALAX (View Miralax Review and Miralax Label ), ARICEPT (View Aricept Review and Aricept Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), NAMENDA (View Namenda Review and Namenda Label ). Patient was hospitalized.